Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Va
A retrospective, multinational, multicentre, observational study in patients presenting with native severe aortic valve stenosis and treated with Myval™ Transcatheter Heart Valve Series in real-world setting.
| Condition(s) | Aortic Valve Stenosis |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | A retrospective, multinational, multicentre, observational study in patients presenting with native severe aortic valve stenosis and treated with Myval™ Transcatheter Heart Valve Series in real-world setting. |
| Who can participate | Inclusion Criteria: * All patients of this study must have received Myval™ THV series for treatment of native severe aortic stenosis and completed a minimum of 30-day follow-up. Exclusion Criteria: * No |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Meril Life Sciences Pvt. Ltd. |
| Locations | Tallinn, Estonia; Milan, Italy; Breda, North Brabant, Netherlands; Gdansk, Bażyńskiego, Poland; Ljubljana, Slovenia; Las Palmas de Gran Canaria, Spain (+2 more sites) |
| Start date | 2020-08-07 |
| NCT ID | NCT04703699 |
| Official listing | https://clinicaltrials.gov/study/NCT04703699 |